Court denies injunction blocking Surmodics acquisition by GTCR

Go back to Court denies injunction blocking Surmodics acquisition by GTCR

Surmodics Announces U.S. District Court Denies Request for Preliminary Injunction to Block Proposed Acquisition by GTCR

November 10, 2025 7:00 PM UTC

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- Surmodics, Inc. (Nasdaq: SRDX) (Surmodics or the Company), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that the United States District Court for the Northern District of Illinois (the District Court) has denied a request by the U.S. Federal Trade Commission (the FTC) and certain state regulators to issue a preliminary injunction that would have prevented the Company and GTCR LLC (GTCR) from consummating the proposed acquisition of the Company by an affiliate of GTCR (the Merger).

Consummation of the... More